U.S. Dengue Testing Market is expected to grow at a steady rate, growing from USD 148.35 Million in 2025 to USD 223.40 Million in 2035 owing to high rapid diagnostic tests’ adoption ratesAustin, April ...
Yuven Gouden, spokesperson for SAHPRA, told GroundUp that antigen tests “are not helpful to guide decision-making regarding ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Learn about prostate cancer risks, warning signs, and the importance of PSA testing for early detection and treatment.
Herbal treatments such as saw palmetto are commonly used to relieve symptoms of benign prostatic enlargement (BPE). However, ...
Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the ...
Prostate cancer is not new. It is not rare. And, in many cases, it is not even immediately fatal. Yet in Nigeria, it ...
EDMONTON, AB, April 20, 2026 /PRNewswire/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX (R) platform, today announced the publication of a ...
AN ANNUAL free prostate cancer screening for men aged 40 and above has been proposed at the Cebu City Council to strengthen ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results